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The National Toxicology Program has broad responsibilities for expanding the toxicological database on the
cor impact ofchemical interactions withbiological systems, providing data thatstrengthen the scientific foundation
P.# for regulatory decisions, developing and validating alternative test systems, and communicating strategies and
C i g c findings to the scientific community, regulatory agencies, and the public. NTP strategies and approaches are
evolving in a number ofways to meet these responsibilities and to take advantage ofthe emerging opportunities presented by
the tools ofmolecular biology.
The overall objective ofNTP initiatives is to protect public health by more efficiently testing chemicals for toxic effects using a
broad array oftest systems and bygenerating data that can make risk assessments more reliable. Current risk assessment approaches
frequently use default assumptions which reflect an inadequate scientific foundation for assessing risk.and create an unacceptable
amount ofuncertainty. This uncertainty can lead to both over- and under-regulation. The costs ofregulatory decisions are enor-
mous in terms ofindustrycompliance, health costs, andlitigation, yet relatively little money is spent to develop strategies for reduc-
ing uncertainties in risk assessment.
Traditional toxicity tests such as the two-year chronic bioassay to detect carcinogens have been the basis for most regulatory
decisions regarding thesafety ofenvironmental chemicals. However, only a limited numberofthe thousands ofchemicals present in
the environment, forwhich wehave little or no toxicological data, can bestudied by these conventional approaches. Increased appli-
cationofknowledge ofthe mechanisms oftoxicity canhelp in severalways.
First, hazardidentification, which is currentlydone usinganimal bioassays to determinewhetheran environmental agent has the
potential to produce an adverse health effect, can be streamlined by appropriate use ofmechanistic information. The emerging tools
ofmolecular biology, which can characterize interactions ofchemicals with critical target genes, offer tractable approaches for devel-
oping more accurate and inexpensive methods to perform this step. Examples include methods fordetecting receptor-mediated toxi-
cants, use oftransgenic animals, and other alternative/complementary in vivo tests to the rodent bioassay. Promising mechanistic
and predictive methods to identify environmental health risks must be developed, validated, and accepted for regulation. These
approaches coulddramatically increase the number ofenvironmental agents evaluated for toxicity. Although mechanisticapproaches
should be more frequently incorporated into toxicity testing, the chronic bioassay in rodents must be used in many cases, especially
thosewhere mechanistic data are not available andwhenvalidating new methods. Avarietyofsourceswill be usedfor this approach,
includinggrants, contracts, interagency agreements, andintramural research.
Second, assessment ofthe difficultand controversial issueofdose-response relationships must be refined. Data from experimen-
tal animals areusuallyobtainedwith relativelyhigh doses ofchemicals becauseoflimitations in resources and attempts to reduce the
number ofanimals used. This practice requires the extrapolation ofhealth effects to exposure levels in humans much lower than
those forwhich experimental data are available. Depending on the method ofextrapolation used, risk estimates mayvary by several
orders ofmagnitude. Although regulatory decisions on potentially hazardous environmental agents should not be delayed, rather
than use default assumptions, biologically based models need to be applied when appropriate. These models should be based on
quantification ofcritical molecularlesions over awidedose range. The relevance ofamodel can best be determinedwhen mechanis-
tic data are available that permit rational comparisons between observed effects in experimental animals and expected effects in
humans.When using mechanistic approaches in bioassays, dose selection must be developed to maximize the potential for deriving
dose-response relationships. Effective use ofbiologically based models on a wide scale will require an intense effort to refine and
develop methods for translating complex biological data into mathematical terms suitable for risk assessments. These approaches
need to be reviewed andaccepted byboth thescientificand regulatory communities.
More research on comparative mechanisms oftoxicity should focus on both rodent and nonmammalian test systems and be
directed at thedevelopment ofmorerapidand less expensive tests. Mathematical riskassessment models areoften criticizedforinad-
equate linkage to real biological systems. Improvements in model development will require use of the emerging computational
graphics technologies and evaluation ofmodels by multidisciplinary groups composed ofbiologists, mathematicians, epidemiolo-
gists, andregulatoryofficials.
Third, although a great deal ofdata may be available for occupational exposures to toxic chemicals, information on human
exposure to these same chemicals in the general environment is often inadequate and must be improved. Increasing knowledge of
the mechanisms responsible for environmentally induced disease, coupled with the development of sensitive and specific tests to
monitor the presenceofachemical in the bodyoranearlybiological effectofthatchemical, offeropportunities to monitorlow-level
human exposures. Validated exposure markers should be applied to determine the human burden ofchemicals and their possible
health consequences. Inaddition, thedevelopment ofnew tests needs to be encouraged, aswell approaches tovalidate these promis-
ing newtests.
Continued research to enhance our knowledge of gene-environment interactions is needed. Humans vary widely in their
response to pharmaceuticals, lifestyle factors, and environmental agents. For example, some peoplewho smoke cigarettes get cancer
but manydon't, and some people have adverse effects fromdrugtherapieswhereas others don't. The biological bases for these varia-
tions in response are nowbeing discovered. Ofparticular importance are inherited genes thatpredispose an individual to an adverse
health outcome when exposed to certain classes ofchemicals. It is nowpossible, in some cases, to test individuals or populations for
"at-risk genes" and determine the range ofexpected variation in response. When this information is available, it should be used in
risk assessments rather than default methodologies. In some cases, the range ofresponses will be much greater than the default 10-
fold ranges.
The major purpose oftoxicity testing and risk assessment should be prevention ofadverse effects by establishing scientifically
valid safe exposure levels. NIEHS and NTP are attempting to integrate mechanistic data, human data, toxicity test data, and bio-
mathematics to strengthen the scientific foundation on which risk assessments are based. Effective and timely communication with
regulatory agencies, the scientific, environmental, and industrial communities, and the public is an integral part ofthis effort. For
information, contactGeorgeW. Lucier, actingdirector, ETP, (919) 541-3802, FAX(919) 541-3647.
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